Preoperative FDG-PET/CT Is an Important Tool in the Management of Patients with Thick (T4) Melanoma

Table 6

2×2 Table of PET/CT with combined regional and distant metastatic disease.

+ PET/CT regional and metastatic disease	Confirmed regional and metastatic disease
Frequency percent
	(a) Disease present	(b) No disease	Total
(a) Positive test	15	3	18
	25.45	5.45	30.91
(b) Negative test	17	21	38
	30.91	38.18	69.09
Total	32	24	56
	56.36	43.64	100.00